跳至主要内容
临床试验/NCT04761068
NCT04761068招募中不适用

Clinical Outcomes of Patients Undergoing Coronary Artery Bypass Grafting (CABG) Surgery With VEST Supported Venous Grafts

Cardiocentro Ticino13 个研究点 分布在 5 个国家目标入组 1,000 人开始时间: 2017年12月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000
试验地点
13
主要终点
Ischemic driven target vessel revascularization

研究概览

简要总结

This is a prospective, investigator-initiated, multi-center, open label and post-market registry, enrolling patients with atherosclerotic coronary artery disease, scheduled for CABG with at least one SVG bypass.

The registry is designed to evaluate the clinical outcome of CABG surgery with an external support device (VEST) for SVG bypasses.

In each patient, use of the VEST will be according to its approved indications for use and attempt will be made (based on clinical judgement) to support each non-sequential SVG bypass graft with a VEST device.

Subjects will be followed for 5 years, with interim follow ups at 12 and 24 months.

MACCE and EQ5D3L will be documented at every follow up visit.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient scheduled for planned CABG procedure with at least one SVG bypass with pre-planned VEST treatment.
  • Saphenous vein graft length and diameter are adequate for the planned intervention.
  • Patient is willing and able to give their written informed consent to participate in the registry study.
  • Patient is over 18 years of age

排除标准

  • Emergency CABG surgery (cardiogenic shock, inotropic pressure support, IABP)
  • Participating in any other investigational study for either drug or device which can influence collection of valid data under this study

结局指标

主要结局

Ischemic driven target vessel revascularization

时间窗: 5 years post Index CABG

CABG or PCI of VEST supported vein graft or associated target coronary artery

次要结局

  • Myocardial Infarction (MI)(1, 2, and 5 years post index CABG)
  • Survival(1, 2, and 5 years post index CABG)
  • MACCE(1, 2, and 5 years post index CABG)
  • Recurrent revascularization(1, 2, and 5 years post index CABG)

研究者

发起方
Cardiocentro Ticino
申办方类型
Other
责任方
Principal Investigator
主要研究者

Stefanos Demertzis

Head of cardiac surgery

Cardiocentro Ticino

研究点 (13)

Loading locations...

相似试验